UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia

Annals of hepatology, 2015-05, Vol.14 (3), p.389-395

2015

Volltextzugriff (PDF)

Anemia in β-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression

Haematologica (Roma), 2008-01, Vol.93 (1), p.111-115

2008

Volltextzugriff (PDF)

Renal function in patients with β-thalassaemia major: a long-term follow-up study

Nephrology, dialysis, transplantation, 2012-09, Vol.27 (9), p.3547-3551

2012

Volltextzugriff (PDF)

Natural history of hepatitis C in thalassemia major: a long-term prospective study

European journal of haematology, 2013-06, Vol.90 (6), p.501-507

2013

Volltextzugriff (PDF)

Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone

Blood cells, molecules, & diseases, 2010-08, Vol.45 (2), p.136-139

2010

Volltextzugriff (PDF)

CMR Survey In a Large Cohort Of TI Patients

Blood, 2013-11, Vol.122 (21), p.1015-1015

2013

Volltextzugriff (PDF)

A T2 MRI Prospective Survey on Pancreatic Iron in Thalassemia Major Patients Treated with Deferasirox, Deferiprone and Desferrioxamine

Blood, 2014-12, Vol.124 (21), p.4044-4044

2014

Volltextzugriff (PDF)

Thalassemia intermedia is associated with a proatherogenic biochemical phenotype

Blood cells, molecules, & diseases, 2011-04, Vol.46 (4), p.294-299

2011

Volltextzugriff (PDF)

CMR survey in Thalassemia Intermedia patients

Journal of cardiovascular magnetic resonance, 2014-01, Vol.16 (Suppl 1), p.P267-P267, Article P267

2014

Volltextzugriff (PDF)

Down Regulation of Hepcidin and Interleukin 1-Alpha in Pbmc from Patients with Beta thalassemia

Blood, 2008-11, Vol.112 (11), p.2880-2880

2008

Volltextzugriff (PDF)

Evidence for a Proatherogenic Biochemical Phenotype in Beta Thalassemia Minor and Intermedia

Acta haematologica, 2011-01, Vol.126 (2), p.87-94

2011

Volltextzugriff (PDF)

Case report: thalassemia intermedia patient with hypertension non-responsive to combined medical treatment

Pediatric endocrinology reviews : PER, 2011-03, Vol.8 Suppl 2, p.337

2011

Volltextzugriff (PDF)

Human Immunodeficiency Virus and β-thalassemia Major: A "Competition of Guilt" for Pulmonary Arterial Hypertension. Report of A Case and A Review of the Literature

Hemoglobin, 2010-01, Vol.34 (1), p.61-66, Article 61

2010

Volltextzugriff (PDF)

Long-Term Outcome of Iron-Induced Cardiac Disease in Patients with Thalassemia Major Treated with Combined DFP/DFO or DFO Alone

Blood, 2006-11, Vol.108 (11), p.1764-1764

2006

Volltextzugriff (PDF)

Anemia in -thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression

Haematologica (Roma), 2008-01, Vol.93 (1), p.111-115

2008

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia

Anemia in β-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression

Renal function in patients with β-thalassaemia major: a long-term follow-up study

Natural history of hepatitis C in thalassemia major: a long-term prospective study

Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone

CMR Survey In a Large Cohort Of TI Patients

A T2 MRI Prospective Survey on Pancreatic Iron in Thalassemia Major Patients Treated with Deferasirox, Deferiprone and Desferrioxamine

Thalassemia intermedia is associated with a proatherogenic biochemical phenotype

CMR survey in Thalassemia Intermedia patients

Down Regulation of Hepcidin and Interleukin 1-Alpha in Pbmc from Patients with Beta thalassemia

Evidence for a Proatherogenic Biochemical Phenotype in Beta Thalassemia Minor and Intermedia

Case report: thalassemia intermedia patient with hypertension non-responsive to combined medical treatment

Human Immunodeficiency Virus and β-thalassemia Major: A "Competition of Guilt" for Pulmonary Arterial Hypertension. Report of A Case and A Review of the Literature

Long-Term Outcome of Iron-Induced Cardiac Disease in Patients with Thalassemia Major Treated with Combined DFP/DFO or DFO Alone

Anemia in -thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression

Suchergebnisse filtern